Clinical Trials in Oregon (OR) | Oregon Clinical Drug Trials & Studies

You are viewing Clinical Trials In Oregon

Have multiple conditions? Click here

Showing 1-100 of 1109

There are 1109 trials in Oregon

Name	City	State	Zip
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis	Tualatin	OR	97062
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke	Tualatin	OR
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	The Dalles	OR	97058
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	The Dalles	OR	97058
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	The Dalles	OR	97058
PROLIEVEÂ® Post-Marketing Study TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)	Springfield	OR	97477
Validation of Quantitative Ventricular Function Imaging Single Photon Emission Tomography (Spect)Using the D-SPECT Cardiac Camera	Springfield	OR	97440
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Springfield	OR	97477
Substudy to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)	Springfield	OR	97477
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease	Springfield	OR	00000
Ankle Manual Therapy for Ankle Sprains	Sherwood	OR	97140
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Salem	OR	97309
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Salem	OR	97309
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Salem	OR	97309
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Salem	OR	97309
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Salem	OR	97309
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Salem	OR	97309
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Salem	OR	97309
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Salem	OR	97309
Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial	Salem	OR	97309
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer	Salem	OR	97309
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Salem	OR	97309
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Salem	OR	97309
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer	Salem	OR	97309
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers	Salem	OR	97309
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma	Salem	OR	97309
Both Exercise and Adenosine Stress Testing	Salem	OR	97301
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)	Salem	OR	97301
Safety and Efficacy of F2695 SR in Major Depressive Disorder	Salem	OR	97301
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)	Salem	OR	97301
Athena Pelvic Muscle Trainer - DUETS Trial	Roseburg	OR	97470
Smoking-Cessation and Stimulant Treatment (S-CAST)	Roseburg	OR	97470
Telepsychiatry in Rural Youth	Roseburg	OR	97470
Community-based Intergenerational Oral Health Study	Roseburg	OR	97470
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials	Portland	OR	97210
Consent for Use of Stored Patient Specimens for Future Testing	Portland	OR	97210
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy	Portland	OR	97210
Strategic Timing of Antiretroviral Treatment	Portland	OR	97210
Study of NTBC for Tyrosinemia I	Portland	OR	97201
Xcellerated T CellsTM for Non-Hodgkinâ€™s Lymphoma (NHL) Patients	Portland	OR	97201
Albumin in Acute Ischemic Stroke Trial	Portland	OR	97201
Trial of Memantine for Cognitive Impairment in Multiple Sclerosis	Portland	OR	97201
Repository for Inherited Eye Diseases	Portland	OR	97201
Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia	Portland	OR	97201
Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight	Portland	OR	97201
Progesterone for the Treatment of Traumatic Brain Injury	Portland	OR	97201
Efficacy and Safety of Panobinostat (LBH5789) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)	Portland	OR	97201
A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension (FREEDOM-C2)	Portland	OR	97201
Internet-Based Intervention to Improve Mental Health Outcomes for Abused Women	Portland	OR	97201
Study of the Contraceptive Efficacy and Safety of Amphora Gel Compared to Conceptrol Vaginal Gel	Portland	OR	97201
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies	Portland	OR	97201
Study of N-Acetylcysteine in Acute Liver Failure (ALF)	Portland	OR	97201
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy	Portland	OR	97201
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations	Portland	OR	97201
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)	Portland	OR	97201
A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)	Portland	OR	97201
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Portland	OR	97239
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Portland	OR	97239
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer	Portland	OR	97239
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer	Portland	OR	97239
Treating Patients With High-Grade Glioma With IA Carboplatin-based Chemotherapy, With or Without Sodium Thiosulfate	Portland	OR	97239
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Portland	OR	97239
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Portland	OR	97239
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Portland	OR	97239
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Portland	OR	97239
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma	Portland	OR	97239
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer	Portland	OR	97239
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer	Portland	OR	97239
Melphalan With BBBD in Treating Patients With Brain Malignancies	Portland	OR	97239
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Portland	OR	97239
Combination Chemotherapy With BBBD Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma	Portland	OR	97239
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant	Portland	OR	97239
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Portland	OR	97239
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer	Portland	OR	97239
Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia	Portland	OR	97239
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	Portland	OR	97239
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Portland	OR	97239
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Portland	OR	97239
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes	Portland	OR	97239
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Portland	OR	97239
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Portland	OR	97239
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission	Portland	OR	97239
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Portland	OR	97239
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Portland	OR	97239
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia	Portland	OR	97239
Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer	Portland	OR	97239
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Portland	OR	97239
MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia	Portland	OR	97239
Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)	Portland	OR	97239
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Portland	OR	97239
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma	Portland	OR	97239
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Portland	OR	97239
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors	Portland	OR	97239
Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy	Portland	OR	97239
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia	Portland	OR	97239
Cixutumumab and Temsirolimus in Treating Young Patients With Solid Tumors That Have Recurred or Not Responded to Treatment	Portland	OR	97239
Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants	Portland	OR	97239
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Portland	OR	97239
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Portland	OR	97239
Study of Kidney Tumors in Young Patients	Portland	OR	97239

View Clinical Trial Facilities in Oregon

Showing 1-100 of 1109